AU5561973A - Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine - Google Patents

Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine

Info

Publication number
AU5561973A
AU5561973A AU55619/73A AU5561973A AU5561973A AU 5561973 A AU5561973 A AU 5561973A AU 55619/73 A AU55619/73 A AU 55619/73A AU 5561973 A AU5561973 A AU 5561973A AU 5561973 A AU5561973 A AU 5561973A
Authority
AU
Australia
Prior art keywords
carnitine
pharmaceutical composition
composition incorporating
incorporating
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU55619/73A
Inventor
Pramodkumar Premanand Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU5561973A publication Critical patent/AU5561973A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU55619/73A 1972-05-11 1973-05-11 Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine Expired AU5561973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2210572A GB1435916A (en) 1972-05-11 1972-05-11 Pharmaceutical weight-reducing compositions

Publications (1)

Publication Number Publication Date
AU5561973A true AU5561973A (en) 1974-11-14

Family

ID=10173983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55619/73A Expired AU5561973A (en) 1972-05-11 1973-05-11 Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine

Country Status (8)

Country Link
JP (1) JPS4947519A (en)
AU (1) AU5561973A (en)
BE (1) BE799141A (en)
DE (1) DE2323906A1 (en)
FR (1) FR2183979A1 (en)
GB (1) GB1435916A (en)
IL (1) IL42145A0 (en)
NL (1) NL7306507A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (en) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Use of L-carnitine
SE7810946L (en) * 1978-10-20 1980-04-21 Draco Ab METHOD OF TREATING CHRONIC OBSTRUCTIVE AIR DISEASE
SE7810947L (en) * 1978-10-20 1980-04-21 Draco Ab 3-ALKYLXANTHINES
DE3026368A1 (en) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München NUTRITIONAL SOLUTION FOR COMPLETE PARENTERAL NUTRITION AND FOR ENHANCED ENERGY PRODUCTION
IT1157238B (en) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti USE OF 1-CARNITINA TO IMPROVE THE BIOCHEMICAL AND BEHAVIORAL PARAMENTS OF THE SENILE AGE
FR2619007B1 (en) * 1987-08-07 1990-09-28 Dermatologiques Et COSMETIC PREPARATIONS WITH LIPOLYTIC ACTION
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
CA2159989C (en) * 1993-05-06 1994-11-24 Norton P. Peet 8-substituted xanthines as selective adenosine receptor agents
AT413943B (en) * 2004-03-05 2006-07-15 Lohninger Alfred Dr L-CARNITINE-CONTAINING, ORAL ADMINISTRATIVE COMPOSITION
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Also Published As

Publication number Publication date
FR2183979A1 (en) 1973-12-21
IL42145A0 (en) 1973-06-29
GB1435916A (en) 1976-05-19
BE799141A (en) 1973-11-05
DE2323906A1 (en) 1973-11-22
JPS4947519A (en) 1974-05-08
NL7306507A (en) 1973-11-13

Similar Documents

Publication Publication Date Title
AU5978173A (en) Softener-detergent composition
ZA731808B (en) Pharmaceutical compositions
AU6294173A (en) Therapeutic composition
ZA733811B (en) Pharmaceutical compositions containing cysteine
MY7800368A (en) Pharmaceutical composition
ZA733406B (en) Pharmaceutical formulations
ZA732269B (en) Dermatological compositions
AU5561973A (en) Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
MY7700009A (en) Pharmaceutical compositions containing bischromonyloxy compounds
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
AU6277273A (en) Deodoeant composition
ZA731012B (en) Pharmaceutical compositions
ZA732439B (en) Pharmaceutical composition
ZA713877B (en) Pharmaceutical composition
ZA738187B (en) Pharmaceutical composition and preparation thereof
HK1278A (en) Pharmaceutical formulations
IL41564A0 (en) Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives
ZA734331B (en) Pharmaceutical compositions
ZA735099B (en) Pharmaceutical composition
AU5207873A (en) Pharmaceutical compositions
MY7900236A (en) Pharmaceutical wypolipidemic compositions
AU6063773A (en) Pharmaceutical compositions
AU5790673A (en) Composition
AU478574B2 (en) Pharmaceutical composition